Ondansetron oral
Full descriptor
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Details
- Code
- Q0162
- Short descriptor
- Ondansetron oral
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 1 2012
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Chlorpromazine hcl 5mg oral
Diphenhydramine hcl 50mg
Prochlorperazine maleate 5mg
Granisetron hcl 1 mg oral
Dronabinol 2.5mg oral
Promethazine hcl 12.5mg oral
Dronabinol (syndros) 0.1 mg
Trimethobenzamide hcl 250mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.